Cite
Akinyemiju T, Moore JX, Dibaba DT, et al. Correction: Association of baseline inflammatory biomarkers with cancer mortality in the REGARDS cohort. Oncotarget. 2020;11(7):758doi: 10.18632/oncotarget.27480.
Akinyemiju, T., Moore, J. X., Dibaba, D. T., Pisu, M., Goodman, M., Howard, V. J., Safford, M., Gilchrist, S. C., Cushman, M., Long, L., & Judd, S. E. (2020). Correction: Association of baseline inflammatory biomarkers with cancer mortality in the REGARDS cohort. Oncotarget, 11(7), 758. https://doi.org/10.18632/oncotarget.27480
Akinyemiju, Tomi, et al. "Correction: Association of baseline inflammatory biomarkers with cancer mortality in the REGARDS cohort." Oncotarget vol. 11,7 (2020): 758. doi: https://doi.org/10.18632/oncotarget.27480
Akinyemiju T, Moore JX, Dibaba DT, Pisu M, Goodman M, Howard VJ, Safford M, Gilchrist SC, Cushman M, Long L, Judd SE. Correction: Association of baseline inflammatory biomarkers with cancer mortality in the REGARDS cohort. Oncotarget. 2020 Feb 18;11(7):758. doi: 10.18632/oncotarget.27480. eCollection 2020 Feb 18. PMID: 32133050; PMCID: PMC7041933.
Copy
Download .nbib